Form D · Pharmaceuticals

Relypsa Inc

Santa Clara, CA · CIK 0001416792

Offering snapshot reported Dec 11, 2012 · SEC filing

Reported sold
$65M
Offering amount: $80M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 26, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$32.5M$65MAug 10, 2012: $49,677,652.00Aug 10, 2012Oct 5, 2012: $62,412,304.00Oct 5, 2012Dec 11, 2012: $65,000,192.00Dec 11, 2012

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$62,412,304 → $65,000,192
  • Reported investors14 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 11, 2012Amendment$65,000,192$2,587,888vs Oct 5, 201215SEC filing
Oct 5, 2012Amendment$62,412,304$12,734,652vs Aug 10, 201214SEC filing
Aug 10, 2012Initial$49,677,652No comparison13SEC filing
Aug 8, 2011Amendment$70,129,747$35,000,000vs Sep 14, 201012SEC filing
Sep 14, 2010Initial$35,129,747No comparison12SEC filing
Jul 30, 2010Amendment$6,000,060$2,000,020vs May 3, 201011SEC filing
May 3, 2010Initial$4,000,040No comparison11SEC filing
Aug 7, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Nov 2, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Oct 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Oct 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-182532

Source: Form D, filed Dec 11, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lance Berman Executive
Jerry M. Buysse Executive
Paul Hastings Director
Ron Hunt Director
Jim Johnson Executive
Gerrit Klaerner Director, Executive
Ronald Krasnow Executive
Vijay Lathi Director
Claire Lockey Executive
Janis Naeve Director
Deepa Pakianathan Director
Scott Rocklage Director
Thomas Schuetz Director
Jay P. Shepard Director
Jonathan Silverstein Director
Wilhelm Stahl Executive
Klaus Veitinger Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
5301 Patrick Henry Drive
Santa Clara, CA, 95054